Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China · Delayed Price · Currency is CNY 21.49
-0.19 (-0.88%)
At close: Jun 11, 2026
SHE:301089 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,743 | 3,543 | 3,567 | 6,835 | 9,072 | 10,130 | |
Market Cap Growth | -31.13% | -0.67% | -47.81% | -24.66% | -10.45% | - |
Enterprise Value | 2,516 | 3,292 | 3,210 | 6,483 | 8,682 | 10,148 |
Last Close Price | 21.68 | 28.00 | 28.19 | 53.66 | 71.15 | 79.45 |
PE Ratio | - | - | - | 28.12 | 31.66 | 154.17 |
PS Ratio | 7.34 | 9.37 | 8.46 | 8.18 | 11.56 | 20.16 |
PB Ratio | 1.86 | 2.39 | 2.30 | 4.26 | 6.59 | 9.23 |
P/TBV Ratio | 1.97 | 2.52 | 2.43 | 4.50 | 7.02 | 10.00 |
P/FCF Ratio | - | - | 190.19 | - | 75.28 | - |
P/OCF Ratio | 6624.68 | - | 34.75 | 253.57 | 33.74 | 174.08 |
EV/Sales Ratio | 6.73 | 8.70 | 7.61 | 7.76 | 11.06 | 20.20 |
EV/EBITDA Ratio | - | - | 514.34 | 18.72 | 24.93 | 88.37 |
EV/EBIT Ratio | - | - | - | 21.63 | 28.21 | 120.93 |
EV/FCF Ratio | - | - | 171.12 | - | 72.04 | - |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | - | 0.03 | 0.06 |
Debt / EBITDA Ratio | - | - | 0.64 | - | 0.11 | 0.60 |
Debt / FCF Ratio | - | - | 0.23 | - | 0.33 | - |
Net Debt / Equity Ratio | -0.15 | -0.16 | -0.20 | -0.21 | -0.37 | -0.40 |
Net Debt / EBITDA Ratio | 12.34 | 12.49 | -50.62 | -0.98 | -1.46 | -3.79 |
Net Debt / FCF Ratio | 5.66 | 3.43 | -16.84 | 2.14 | -4.21 | 7.98 |
Asset Turnover | 0.22 | 0.22 | 0.23 | 0.45 | 0.49 | 0.43 |
Inventory Turnover | 1.53 | 1.65 | 1.62 | 1.64 | 1.62 | 1.92 |
Quick Ratio | 2.48 | 2.71 | 2.98 | 3.02 | 1.81 | 2.39 |
Current Ratio | 4.11 | 4.01 | 4.10 | 4.23 | 2.39 | 3.13 |
Return on Equity (ROE) | -5.07% | -4.59% | -1.26% | 16.32% | 23.17% | 8.28% |
Return on Assets (ROA) | -3.24% | -3.09% | -1.43% | 10.17% | 11.89% | 4.48% |
Return on Invested Capital (ROIC) | -7.09% | -6.83% | -3.29% | 21.58% | 35.42% | 12.08% |
Return on Capital Employed (ROCE) | -5.80% | -5.60% | -2.60% | 18.20% | 21.70% | 7.40% |
Earnings Yield | -2.79% | -1.97% | -0.56% | 3.56% | 3.16% | 0.65% |
FCF Yield | -1.47% | -1.99% | 0.53% | -2.32% | 1.33% | -0.54% |
Dividend Yield | - | - | - | 0.47% | 0.56% | 0.13% |
Payout Ratio | - | - | - | 20.85% | 5.23% | 12.05% |
Buyback Yield / Dilution | -1.30% | -1.91% | 1.32% | 0.22% | -26.78% | -5.03% |
Total Shareholder Return | -1.30% | -1.91% | 1.32% | 0.69% | -26.22% | -4.91% |